The Procedureless Elipse Gastric Balloon Program: Multicenter Experience in 1770 Consecutive Patients

Area of Science:

• Bariatric surgery and medical devices
• Gastroenterology
• Obesity medicine

Background:

• The Elipse balloon is an innovative, non-endoscopic swallowable device for weight management.
• It is designed to self-empty and be naturally excreted after four months.

Purpose of the Study:

• To assess the safety and efficacy of the Elipse balloon.
• Evaluation was conducted in a large, multicenter patient population.

Main Methods:

• Analysis of data from 1770 consecutive patients using the Elipse balloon.
• Key data points included weight loss, metabolic markers, placement success, device performance, and adverse events.

Main Results:

• Mean weight loss was 13.5 kg, achieving 14.2% total body weight loss (%TBWL).
• Significant improvements were observed in triglycerides, LDL cholesterol, and HbA1c.
• The device demonstrated a high success rate for swallowing (99.9%) with a low incidence of serious complications.

Conclusions:

• The Elipse balloon exhibits an excellent safety profile.
• The device is highly effective, leading to substantial weight loss and metabolic improvements.